Breastcancer.org (@breastcancerorg) 's Twitter Profile
Breastcancer.org

@breastcancerorg

Nonprofit organization dedicated to providing the most reliable, complete, and up-to-date information about breast cancer and breast health.

ID: 31445431

linkhttp://www.breastcancer.org/ calendar_today15-04-2009 16:20:59

10,10K Tweet

21,21K Followers

867 Following

Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

Did you miss this weekend's updates from #ASCO25? Get the highlights on some of the most promising breakthroughs in #breastcancer research āž”ļø bit.ly/ASCO_2025 #BreastCancerResearch #BreastCancerSupport #BCSM

Did you miss this weekend's updates from #ASCO25? Get the highlights on some of the most promising breakthroughs in #breastcancer research 
āž”ļø bit.ly/ASCO_2025

#BreastCancerResearch #BreastCancerSupport #BCSM
Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

#ASCO25 #MetastaticBreastCancer Poster Session: Assessing the impact of #ScalpCooling in patients receiving #TrastuzumabDeruxtecan for metastatic #BreastCancer. Elahe Salehi DNP Abs 1095 | Poster Bd 74 | Jun 2, 9-12 PM CDT | Hall A

#ASCO25 #MetastaticBreastCancer Poster Session: Assessing the impact of #ScalpCooling in patients receiving #TrastuzumabDeruxtecan for metastatic #BreastCancer. <a href="/esalehiDNP/">Elahe Salehi DNP</a> 
Abs 1095 | Poster Bd 74 | Jun 2, 9-12 PM CDT | Hall A
Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

#ASCO25 #MetastaticBreastCancer Poster Session: A phase 1b study of #Plk1 inhibitor onvansertib in combination with paclitaxel in metastatic triple-negative breast cancer (#mTNBC) patients. Abstract 1100 | Poster Bd 79 | 9-12 PM CDT | Hall A Antonio Giordano, MD PhD Sara Tolaney Dr Sarah Sammons

#ASCO25 #MetastaticBreastCancer Poster Session:
A phase 1b study of #Plk1 inhibitor onvansertib in combination with paclitaxel in metastatic triple-negative breast cancer (#mTNBC) patients.
Abstract 1100 | Poster Bd 79 | 9-12 PM CDT | Hall A
<a href="/antgiorda/">Antonio Giordano, MD PhD</a> <a href="/stolaney1/">Sara Tolaney</a> <a href="/drsarahsam/">Dr Sarah Sammons</a>
Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

Happening Now! #ASCO25 Poster Session šŸ‘‰Association between chemotherapy use and clinical outcomes in young BRCA carriers with T1N0 #BreastCancer: Results from an international cohort study. Filipa Lynce, MD, FASCO šŸ‡µšŸ‡¹ šŸ‡ŗšŸ‡ø Matteo Lambertini, MD PhD Ann Partridge MD, MPH šŸ“Abs 541 | Poster Bd134 | Jun 2, 9-12 PM CDT

Happening Now! #ASCO25 Poster Session šŸ‘‰Association between chemotherapy use and clinical outcomes in young BRCA carriers with T1N0 #BreastCancer: Results from an international cohort study. <a href="/FilipaLynce/">Filipa Lynce, MD, FASCO šŸ‡µšŸ‡¹ šŸ‡ŗšŸ‡ø</a> <a href="/matteolambe/">Matteo Lambertini, MD PhD</a> <a href="/AnnPartridgeMD/">Ann Partridge MD, MPH</a> 
šŸ“Abs 541 | Poster Bd134 | Jun 2, 9-12 PM CDT
Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

New PodcastšŸŽ™ļøbit.ly/4kLljlJ šŸŽ§Listen to our latest podcast episode to hear our discussion with Eleonora Teplinsky, MD about the top 3 breast cancer research studies presented at #ASCO2025 #metastaticbreastcancer #mbcwarrior #metavivor #podcast #breastcancersupport #breastcancer

New PodcastšŸŽ™ļøbit.ly/4kLljlJ

šŸŽ§Listen to our latest podcast episode to hear our discussion with <a href="/drteplinsky/">Eleonora Teplinsky, MD</a> about the top 3 breast cancer research studies presented at #ASCO2025 

#metastaticbreastcancer #mbcwarrior #metavivor #podcast #breastcancersupport #breastcancer
Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

New study prsented #ASCO2025 shows vepdegestrant may help people with ESR1-mutated breast cancer. Read morešŸ”—bit.ly/3Fz3uHD šŸ“£ Key Research Takeaways • Cancer stayed under control longer (5 months vs. 2 months) • More cancers shrank (19% vs. 4%) • Serious side

New study prsented #ASCO2025 shows vepdegestrant may help people with ESR1-mutated breast cancer. Read morešŸ”—bit.ly/3Fz3uHD

šŸ“£ Key Research Takeaways

• Cancer stayed under control longer
   (5 months vs. 2 months)

• More cancers shrank (19% vs. 4%)

• Serious side
Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

We created this resource just for you — because everyone deserves affirming cancer care. 🌈 Find providers who see all of who you are. šŸ”— Access the full resource: bit.ly/4dQDAfe #PrideMonth #LGBTQHealth #CancerCare #BreastCancerSupport

We created this resource just for you — because everyone deserves affirming cancer care. 🌈

Find providers who see all of who you are.
šŸ”— Access the full resource: bit.ly/4dQDAfe
#PrideMonth #LGBTQHealth #CancerCare #BreastCancerSupport
Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

Mental health support is an essential part of breast cancer care. Watch our most recent webinar to discover different evidence-based strategies and tools to help you cope with the various feelings that can come with a diagnosis. Watch now šŸŽ„ bit.ly/43FuwF5 Thank you to

Mental health support is an essential part of breast cancer care. Watch our most recent webinar to discover different evidence-based strategies and tools to help you cope with the various feelings that can come with a diagnosis. Watch now šŸŽ„ bit.ly/43FuwF5

Thank you to
Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

OASIS-4 Phase 3 trial results presented at #ASCO25 show that elinzanetant—a neurokinin-targeted therapy—can reduce moderate to severe vasomotor symptoms (hot flashes) in people taking endocrine therapy for HR+ breast cancer. Read more #BreastCancerResearch highlights here:

OASIS-4 Phase 3 trial results presented at #ASCO25 show that elinzanetant—a neurokinin-targeted therapy—can reduce moderate to severe vasomotor symptoms (hot flashes)  in people taking endocrine therapy for HR+ breast cancer.

Read more #BreastCancerResearch highlights here:
Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

In this podcast episode, Dr. Kathryn Schmitz (Dr Kathryn Schmitz) shares why exercise isn’t just safe during cancer treatment—it’s essential. She discusses how to build movement into care plans and highlights new research showing that exercise improved survival for people with

In this podcast episode, Dr. Kathryn Schmitz (<a href="/fitaftercancer/">Dr Kathryn Schmitz</a>) shares why exercise isn’t just safe during cancer treatment—it’s essential.

She discusses how to build movement into care plans and highlights new research showing that exercise improved survival for people with
Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

People diagnosed with metastatic HER2-positive #breastcancer who received Enhertu and Perjeta as a first treatment had a lower risk of the cancer growing or death than people who received the standard of care Taxol-Herceptin-Perjeta (THP) regimen. #ASCO2025 Read more šŸ”—

People diagnosed with metastatic HER2-positive #breastcancer who received Enhertu and Perjeta as a first treatment had a lower risk of the cancer growing or death than people who received the standard of care Taxol-Herceptin-Perjeta (THP) regimen. #ASCO2025

Read more šŸ”—
Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

Making decisions about breast reconstruction can feel overwhelming. We’re here to help. Register today for our free ā€œAsk Me Anything: Breast Reconstructionā€ event on June 17 and get trusted answers from experienced plastic surgeons. bit.ly/43wev4B #Breastcancer

Making decisions about breast reconstruction can feel overwhelming. We’re here to help.

Register today for our free ā€œAsk Me Anything: Breast Reconstructionā€  event on June 17 and get trusted answers from experienced plastic surgeons.
bit.ly/43wev4B

#Breastcancer
Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

If you’ve been diagnosed with breast cancer and don’t have insurance, you may qualify for Medicaid—even if your income is too high for other programs. Every state has a Breast and Cervical Cancer Treatment Program that could help cover your care, sometimes for free. šŸ”— Learn

If you’ve been diagnosed with breast cancer and don’t have insurance, you may qualify for Medicaid—even if your income is too high for other programs.
Every state has a Breast and Cervical Cancer Treatment Program that could help cover your care, sometimes for free.
šŸ”— Learn
Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

If you’re spending time in the sun, the benefits of using sunscreen will almost always outweigh any risks. Here’s what to know and sun protection options to consider if you are concerned about the chemicals in sunscreen.ā˜€ļø bit.ly/4dabURh #breastcancerrisk #sunsafety

If you’re spending time in the sun, the benefits of using sunscreen will almost always outweigh any risks. 

Here’s what to know and sun protection options to consider if you are concerned about the chemicals in sunscreen.ā˜€ļø bit.ly/4dabURh

#breastcancerrisk #sunsafety
Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

While breast cancer is rare in men, it can happen. This #MensHealthWeek, learn what factors can increase a man’s breast cancer risk. šŸ”—bit.ly/3XchT0U #breastcancerrisk #breastcancer #malebreastcancer

While breast cancer is rare in men, it can happen. This #MensHealthWeek, learn what factors can increase a man’s breast cancer risk. šŸ”—bit.ly/3XchT0U 

#breastcancerrisk #breastcancer #malebreastcancer